<unk> <unk>  Streptococcus (GBS) causes invasive disease primarily in infants, pregnant or postpartum women, and older adults, with the highest incidence among young infants. <unk> efore active prevention was initiated, an estimated 7,500 cases of neonatal GBS disease occurred annually in the United States. Striking declines in disease incidence coincided with increased prevention activities in the 1990s, and a further reduction occurred following the issuance of the recommendation for universal screening in 2002.  However, GBS disease remains the leading<unk> s cause of morbidity and mortality among newborns in the United States.  The continued<unk> urden of disease and newly available data relevant to early-onset GBS disease prevention from the fields of epidemiology, obstetrics, neonatology, microbiology, molecular<unk> iology, and pharmacology prompted revision of the guidelines for early-onset GBS disease prevention.
Group B streptococcal infection epidemiology and demographics
Diphtheria epidemiology and demographics
Strep throat epidemiology and demographics
Typhoid fever epidemiology and demographics
Listeriosis epidemiology and demographics
Kawasaki disease epidemiology and demographics
Scarlet fever epidemiology and demographics
Vertigo epidemiology and demographics